Merck KGaA reported earnings results for the fourth quarter and full year ended December 31, 2025. For the fourth quarter, the company reported sales was EUR 5,248.6 million compared to EUR 5,417.7 million a year ago. Net income was EUR 319.2 million compared to EUR 666.2 million a year ago.
For the full year, sales was EUR 21,102 million compared to EUR 21,156 million a year ago. Net income was EUR 2,608 million compared to EUR 2,777 million a year ago. Basic earnings per share from continuing operations was EUR 6 compared to EUR 6.39 a year ago. Diluted earnings per share from continuing operations was EUR 6 compared to EUR 6.39 a year ago.